Skip to content
PharmaManufacturingIQ

Q&A: Is the key to personalised medicine programmability?

Sail Biomedicines’ Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail’s tailored Endless RNATM (eRNATM) medicines.

By PharmaManufacturing IQ Staff
Q&A: Is the key to personalised medicine programmability?
Published: | 4 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Sail Biomedicines’ Kerry Benenato and Rajesh Ramaswamy discuss the roles artificial intelligence (AI) can play in informing programmability, using the example of Sail’s tailored Endless RNATM (eRNATM) medicines and addressable nanoparticle delivery vehicles. 

Maks_lab Shutterstock

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information